Search Results
1
Study Matches
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) (APOLLO)
The APOLLO study is being done in an attempt to improve outcomes after kidney transplantation
and to improve the safety of living kidney donation based upon variation in the
apolipoprotein L1 gene (APOL1). Genes control what is inherited from a family, such as eye
color or blood type. Variation in APOL1 can cause kidney disease. African Americans,
Afro-Caribbeans, Hispanic Blacks, and Africans are more likely to have the APOL1 gene
variants that cause kidney disease. APOLLO will test DNA from kidney donors and recipients of
kidney transplants for APOL1 to determine effects on kidney transplant-related outcomes.
Brad Astor, PhD, MPH
All
Not specified
NA
NCT03615235
Kidney Diseases, Kidney Failure, Kidney Disease, Chronic, Other